add to folder:

Folders shared with you

  • The Federal Trade Commission (“FTC”) cleared a final settlement with the German multinational chemical company BASF SE and its US subsidiary, as well as the BASF-owned marketing company DIEM Labs, LLC (collectively “BASF”) to clarify the allegations made by BASF made misleading and scientifically unsupported claims marketing its dietary fish oil supplements in violation of FTC law.
  • The complaint alleged that BASF was deceptively promoting two fish oil supplements that are rich in omega-3 fatty acids and have been clinically proven to reduce liver fat in people with non-alcoholic fatty liver disease (NAFLD).
  • Under the terms of the final approval orders, BASF pays $ 416,914 to the FTC for consumer refunds and is not allowed to claim that a product containing one or more omega-3 fatty acids can reduce liver fat in people with NAFLD or help with other disease unless supported by scientific evidence in the form of randomized human clinical studies.

add to folder:

Folders shared with you

Popular items from this company

To learn how Lexology can advance your content marketing strategy, please email [email protected].

LEAVE A REPLY

Please enter your comment!
Please enter your name here